In a study by Park et al., CD34+ cells isolated from the PLC/PRF/5 hepatoma cell line were found to function as TICs, capable of generating HCC, cholangiocarcinoma (CC), and combined hepatocellular cholangiocarcinoma (CHC) in immunodeficient mice (17). Here, CD34 is linked to hepatocellular carcinoma.